Paradigm Research Professionals, LLC

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Depression3 trials

Phase

• Phase 21 trial
• Phase 31 trial
• Phase 41 trial

Status

• Completed3 trials

Lead sponsor

• Janssen Research & Development, LLC3 trials

Closed trials

• Completed

  A Study to Explore the Efficacy of JNJ-89495120 in the Treatment of Major Depressive Disorder

  NCT06785012· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

  NCT05550532· Phase 3· Janssen Research & Development, LLC· Source

• Completed

  A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression

  NCT04599855· Phase 4· Janssen Research & Development, LLC· Source